Donal O’Callaghan, founder and CEO of Callaghan Engineering, an Irish engineering and construction firm, tells us what motivated him to break into the pharma market in 1990, the changes in the industry he has seen, and his ambition to position Callaghan Engineering as an engineering house of choice.
You founded Callaghan Engineering in 1990. What is the story behind that decision?
"We do continue to work on a number of API plants in Ireland. It is a bit like going back to where we started, which is nice. Generally speaking though, we would have grown alongside our clients as they themselves moved from API to secondary to biopharma production, maturing with the sector."
